Pénzváltó, Z., Lánczky, A., Lénárt, J., Meggyesházi, N., Krenács, T., Szoboszlai, N., . . . Győrffy, B. (2014). MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer. BMC Cancer.
Citação norma ChicagoPénzváltó, Zsófia, András Lánczky, Julianna Lénárt, Nóra Meggyesházi, Tibor Krenács, Norbert Szoboszlai, Carsten Denkert, Imre Pete, and Balázs Győrffy. "MEK1 Is Associated With Carboplatin Resistance and Is a Prognostic Biomarker in Epithelial Ovarian Cancer." BMC Cancer 2014.
Citação norma MLAPénzváltó, Zsófia, et al. "MEK1 Is Associated With Carboplatin Resistance and Is a Prognostic Biomarker in Epithelial Ovarian Cancer." BMC Cancer 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.